TOMUZOTUXIMAB
UNII 5P637IXG16

Substance Identification & Data

This profile provides standardized clinical and technical data for Tomuzotuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5P637IXG16.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1646321-00-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5P637IXG16

CAS Registry Number

1646321-00-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOMUZOTUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152692

National Cancer Institute reference terminology for clinical and research data.

INN ID

10334

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tomuzotuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOMUZOTUXIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C225 .KAPPA.-CHAIN, DIMER, GLYCOFORM

TOMUZOTUXIMAB [INN]

TOMUZOTUXIMAB [WHO-DD]

External Clinical & Regulatory Resources

Previous UNII5P60F84FBH

Next UNII5P66783GRV